危重病儿童外显子组中的风险变异
本文为遗传关联研究,在267名儿童(含22名病毒性呼吸衰竭既往健康儿童、18名死于细支气管炎儿童)及9990名对照中筛查外显子组致病变异。228名儿童(80%)未获遗传诊断;质控后231名儿童在LOEUF≤0.680的不耐受基因中携带过量罕见LOF变异(P=1.0×10⁻⁵)。176名未诊断儿童在无已知疾病关联的不耐受基因中携带过量超罕见LOF变异(OR 1.8,95%CI 1.3-2.5);25名病毒性呼吸衰竭儿童同样仅在无已知疾病关联基因中富集(OR 2.8,95%CI 1.1-6.6)。114名未诊断儿童的新发LOF变异富集(观察14 vs 预期6.8,富集2.05)。作者认为未来研究可能将表型与致病基因关联。
要点
- 228/285名危重病儿童(80%)外显子组测序未获遗传诊断。
- 质控后231名儿童在LOEUF≤0.680的不耐受基因中罕见LOF变异过量(P=1.0×10⁻⁵)。
- 176名未诊断儿童在无已知疾病关联的不耐受基因中超罕见LOF变异富集(OR 1.8,95%CI 1.3-2.5)。
- 25名病毒性呼吸衰竭儿童在无已知疾病关联的不耐受基因中超罕见LOF变异富集(OR 2.8,95%CI 1.1-6.6)。
- 114名未诊断儿童新发LOF变异富集(观察14 vs 预期6.8,富集2.05)。
适用人群与场景
- 267名在摩根士丹利儿童医院(纽约长老会医院)接受外显子组测序的儿童,其中22名为既往健康且患病毒性呼吸衰竭的儿童
- 18名来自纽约市首席法医办公室的死于细支气管炎的儿童,其中14名既往健康
- 9990名来自哥伦比亚大学欧文医学中心基因组医学研究所的对照
诊断标准与关键阈值
- 功能丧失观察/预期上限分数(LOEUF)≤0.680定义为不耐受基因
研究设计与关键结果
- 研究类型为遗传关联研究,纳入285名危重病儿童(中位[范围]年龄4.1[0-18.9]岁;148名[52%]男性)和9990名对照。
- 228名儿童(80%)未获得遗传诊断。
- 质控后,231名儿童在LOEUF≤0.680的不耐受基因中携带过量罕见LOF变异(P=1.0×10⁻⁵)。
- 质控后,176名未诊断儿童在不耐受基因中携带过量超罕见LOF变异,但仅见于无已知疾病关联的基因(OR 1.8,95%CI 1.3-2.5)。
- 质控后,25名病毒性呼吸衰竭儿童在不耐受基因中携带过量超罕见LOF变异,但仅见于无已知疾病关联的基因(OR 2.8,95%CI 1.1-6.6)。
- 114名未诊断儿童在无已知疾病关联的基因中富集新发LOF变异(观察14 vs 预期6.8,富集2.05)。
证据类型、等级与局限
- 证据类型:遗传关联研究
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,未来研究可能将表型与致病基因关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Diagnostic genetic testing can lead to changes in management in the pediatric intensive care unit. Genetic risk in children with critical illness but nondiagnostic exome sequencing (ES) has not been explored.
OBJECTIVE: To assess the association between loss-of-function (LOF) variants and pediatric critical illness.
DESIGN, SETTING, AND PARTICIPANTS: This genetic association study examined ES first screened for causative variants among 267 children at the Morgan Stanley Children's Hospital of NewYork-Presbyterian, of whom 22 were otherwise healthy with viral respiratory failure; 18 deceased children with bronchiolitis from the Office of the Chief Medical Examiner of New York City, of whom 14 were previously healthy; and 9990 controls from the Institute for Genomic Medicine at Columbia University Irving Medical Center. The ES data were generated between January 1, 2015, and December 31, 2020, and analyzed between January 1, 2017, and September 2, 2022.
EXPOSURE: Critical illness.
MAIN OUTCOMES AND MEASURES: Odds ratios and P values for genes and gene-sets enriched for rare LOF variants and the loss-of-function observed/expected upper bound fraction (LOEUF) score at which cases have a significant enrichment.
RESULTS: This study included 285 children with critical illness (median [range] age, 4.1 [0-18.9] years; 148 [52%] male) and 9990 controls. A total of 228 children (80%) did not receive a genetic diagnosis. After quality control (QC), 231 children harbored excess rare LOF variants in genes with a LOEUF score of 0.680 or less (intolerant genes) (P = 1.0 × 10-5). After QC, 176 children without a diagnosis harbored excess ultrarare LOF variants in intolerant genes but only in those without a known disease association (odds ratio, 1.8; 95% CI, 1.3-2.5). After QC, 25 children with viral respiratory failure harbored excess ultrarare LOF variants in intolerant genes but only in those without a known disease association (odds ratio, 2.8; 95% CI, 1.1-6.6). A total of 114 undiagnosed children were enriched for de novo LOF variants in genes without a known disease association (observed, 14; expected, 6.8; enrichment, 2.05).
CONCLUSIONS AND RELEVANCE: In this genetic association study, excess LOF variants were observed among critically ill children despite nondiagnostic ES. Variants lay in genes without a known disease association, suggesting future investigation may connect phenotypes to causative genes.
参考来源
- Motelow JE, Lippa NC, Hostyk J, et al. Risk Variants in the Exomes of Children With Critical Illness. JAMA Netw Open. 2022. PMID: 36306130. doi:10.1001/jamanetworkopen.2022.39122
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。